Double Blind, Placebo Controlled, Dose Ranging and Methotrexate Interaction Study for the Assessment of Safety, Tolerability and Pharmacokinetics (PK) of Multiple Oral Doses of GLPG0259 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2012
At a glance
- Drugs GLPG 0259 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Biomarker
- 16 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.